United Therapeutics Corp. (UTHR)

$ 313.39
   
  • Change Today:
    $2.73
  • 52 Week High: $410.00
  • 52 Week Low: $274.70
  • Currency: US Dollars
  • Shares Issued: 43.56m
  • Volume: 308,596
  • Market Cap: $13,652m
  • RiskGrade: 132
  • Beta: 0.01

Latest ShareCast News

GlaxoSmithKline reportedly running the ruler over US rival

By Alexander Bueso

Date: Friday 04 Aug 2017

(ShareCast News) - GlaxoSmithKline may be studying a possible bid for US rival United Therapeutics, The Evening Standard reported citing City sources.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

UTHR Market Data

Currency US Dollars
Share Price $ 313.39
Change Today $ 2.73
% Change 0.88 %
52 Week High $410.00
52 Week Low $274.70
Volume 308,596
Shares Issued 43.56m
Market Cap $13,652m
Beta 0.01
RiskGrade 132

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 5
Sell 0
Strong Sell 0
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-Aug-2025

Time Volume / Share Price
14:50 100 @ $313.39
14:50 200 @ $313.52
14:50 100 @ $313.60
14:49 100 @ $313.61
14:49 300 @ $313.81

Top of Page